Skip to main content
Log in

Penetration of Cefaclor Into the Interstitial Space Fluid of Skeletal Muscle and Lung Tissue in Rats

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose. To measure and compare the penetration of cefaclor from the plasma compartment into the interstitial space of lung and skeletal muscle in rats and to integrate the data in a pharmacokinetic model.

Methods. Unbound interstitial concentrations in muscle and lung were measured by in vivo microdialysis following i.v. bolus doses of 50 and 75 mg/kg cefaclor. Unbound muscle concentrations were also measured after a primed, continuous i.v. infusion at an infusion rate of 0.3 mg/kg/min.

Results. The cefaclor half-life in plasma, muscle and lung was approximately 1 h. Unbound cefaclor concentrations in muscle and lung were found to be virtually identical. A 2-compartment body model was fitted to the data with a tissue penetration factor (AUCtissue(unbound)/AUCplasma(unbound)) of approximately 0.26 independent of dose, tissue and mode of administration.

Conclusions. Unbound concentrations of cefaclor in the interstitial space fluid of lung and skeletal muscle are of similar magnitude and lower than those in plasma. Using total plasma concentrations would overestimate the antibacterial activity of the drug and therefore its clinical efficacy. Instead, therapeutically active levels of cefaclor at the site of action should be taken into account. Microdialysis allows direct measurement of these unbound concentrations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. T. Dalla Costa, A. Nolting, A. Kovar, and H. Derendorf. Determination of free interstitial concentrations of piperacillin-tazobactam combinations by microdialysis. J. Antimicrob. Chemother. 42:769–78 (1998).

    Google Scholar 

  2. Y. DeGuchi, T. Terasaki, H. Yamada, and A. Tsuji. An application of microdialysis to drug tissue distribution study: in vivo evidence for free-ligand hypothesis and tissue binding of beta-lactam antibiotics in interstitial fluids. J. Pharmacobiodyn. 15:79–89 (1992).

    Google Scholar 

  3. A. Nolting, T. Dalla Costa, R. Vistelle, K. H. Rand, and H. Derendorf. Determination of Free Extracellular Concentrations of Piperacillin by Microdialysis. J. Pharm. Sci. 85:369–372 (1996).

    Google Scholar 

  4. A. Kovar, T. Dalla Costa, and H. Derendorf. Comparison of plasma and free tissue levels of ceftriaxone in rats by microdialysis. J. Pharm. Sci. 86:52–56 (1996).

    Google Scholar 

  5. G. R. Fleisher, C. M. Wilmott, J. M. Campos. Amoxicillin combined with clavulanic acid for the treatment of soft tissue infections in children. Antimicrob. Agents. Chemother. 24:679–681 (1983).

    Google Scholar 

  6. C. Joukhadar, M. Frossard, B. X. Mayer, M. N. Brunner, Klein, P. Siostrzonek, H. G. Eichler, and M. Muller. Impaired target site penetration of beta-lactams may account for therapeutic failure in patients with septic shock. Crit. Care Med. 29:385–391 (2001).

    Google Scholar 

  7. J. Martin-Villacorta and R. Mendez, Effect of Temperature and Mobile Phase Composition on RP-HPLC Separation of Cephalosporins. J. Liq. Chrom. 13:3269–3288 (1990).

    Google Scholar 

  8. J. Blanchard. Evaluation of the relative efficacy of various techniques for deproteinizing plasma samples prior to high-performance liquid chromatographic analysis. J. Chromatogr. 226:455–460 (1981).

    Google Scholar 

  9. S. W. Baertschi, D. E. Dorman, J. L. Occolowitz, M. W. Collins, L. A. Spangle, G. A. Stephenson, and L. J. Lorenz. Isolation and Structure Elucidation of the Major Degradation Products of Cefaclor formed under Aqueous Acidic Conditions. J. Pharm. Sci. 86:526–539 (1997).

    Google Scholar 

  10. M. A. Foglesong, J. W. Lamb, and J. V. Dietz, Stability and blood level determinations of cefaclor, a new oral cephalosporin antibiotic. Antimicrob. Agents Chemother. 13:49–52 (1978).

    Google Scholar 

  11. A. P. Gillett, J. M. Andrews, and R. Wise. Comparative in vitro microbiological activity and stability of cefaclor. Postgrad. Med. J. 55:9–11 (1979).

    Google Scholar 

  12. S. W. Baertschi, D. E. Dorman, J. L. Occolowitz, L. A. Spangle, M. W. Collins, M. E. Wildfeuer, and L. J. Lorenz. Isolation and structure elucidation of a novel product of the acidic degradation of cefaclor. J. Pharm. Sci. 82:622–626 (1993).

    Google Scholar 

  13. H. Sourgens, H. Derendorf, and H. Schifferer, Pharmacokinetic profile of cefaclor. Int. J. Clin. Pharm. Ther. 35:374–380 (1997).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

de la Penña, A., Dalla Costa, T., Talton, J.D. et al. Penetration of Cefaclor Into the Interstitial Space Fluid of Skeletal Muscle and Lung Tissue in Rats. Pharm Res 18, 1310–1314 (2001). https://doi.org/10.1023/A:1013042128791

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1013042128791

Navigation